---
title: "Huafu Securities Sticks to Its Buy Rating for BeOne Medicines Ltd (6160)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291881047.md"
description: "In a report released yesterday, from Huafu Securities maintained a Buy rating on BeOne Medicines Ltd, with a price target of HK$297.44.4th of July Sale - 70% Off Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions. Discover top stock picks and new investment opportunities through TipRanks' Smart Investor Newsletter. The word on The Street in general, suggests a Strong Buy analyst consensus rating for BeOne Medicines Ltd with a HK$261.60 average price target."
datetime: "2026-07-07T05:15:18.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291881047.md)
  - [en](https://longbridge.com/en/news/291881047.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291881047.md)
generator: "portal-rs"
---

# Huafu Securities Sticks to Its Buy Rating for BeOne Medicines Ltd (6160)

In a report released yesterday, from Huafu Securities maintained a Buy rating on BeOne Medicines Ltd, with a price target of HK$297.44.

### 4th of July Sale - 70% Off

-   Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions.
-   Discover top stock picks and new investment opportunities through TipRanks' Smart Investor Newsletter.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for BeOne Medicines Ltd with a HK$261.60 average price target.

### Related Stocks

- [ONC.US](https://longbridge.com/en/quote/ONC.US.md)
- [BGNE.US](https://longbridge.com/en/quote/BGNE.US.md)
- [688235.CN](https://longbridge.com/en/quote/688235.CN.md)
- [06160.HK](https://longbridge.com/en/quote/06160.HK.md)

## Related News & Research

- [BeOne Medicines Announces Voluntary Agreement with U.S. Government to Expand Access to Innovative Cancer Medicines | ONC Stock News](https://longbridge.com/en/news/297552849.md)
- [How Investors Are Reacting To BeOne Medicines (ONC) First-Line HER2-Positive GEA Immunotherapy Approval](https://longbridge.com/en/news/297146976.md)
- [BeOne Medicines to Present at the Morgan Stanley Annual Global Healthcare Conference | ONC Stock News](https://longbridge.com/en/news/297636674.md)
- [AcuCort notifies availability of August 2026 newsletter press release](https://longbridge.com/en/news/297505730.md)
- [Cogent Communications CFO Thaddeus Gerard Weed sells 4,850 shares for $45,445.99](https://longbridge.com/en/news/297927784.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**